Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mercuries & Associates Holding, Ltd. (2905.TW)
Taipei, TW
Mercuries & Associates Holding, Ltd. operates as an investment holding company with diverse business interests spanning life insurance, retail of everyday commodities and food, pharmaceuticals, and information technology services. Its insurance division provides a comprehensive suite of products, encompassing various life coverage options (lifetime, whole life, variable), health policies (hospitalization, medical, cancer, long-term care, disability), and accident protection (personal, travel, group). Additionally, it offers annuity plans (immediate, deferred, variable) and foreign currency pension products. The retail segment is involved in the procurement and sale of a broad spectrum of goods, ranging from everyday necessities, groceries, alcoholic beverages, and tobacco to fresh produce, medical supplies, infant products, cosmetics, and beauty items. This division also markets branded footwear, apparel, and accessories, alongside operating fast-food establishments serving items like noodles, rice dishes, fried pork chops, Japanese bento sets, and pizzas. Furthermore, it handles the sale and interior decoration of home furnishings, including furniture, cabinets, kitchen equipment, and mattresses. Within its pharmaceutical operations, Mercuries & Associates Holding manufactures active pharmaceutical ingredients (APIs) such as valproic acid and allopurinol. It also produces API intermediates, including diethyl dipropyl malonate and PENT-2 ethyl 2-allyl-2-cyano-3-methylhexanoate, along with specialty chemicals like diethyl ketone. Moreover, the company delivers information technology services, specializing in the planning, development, and implementation of software and hardware solutions for financial systems and public utilities, complemented by ongoing maintenance support. Founded in Taipei, Taiwan, in 1965, the company officially changed its name from Mercuries & Associates, Ltd. to Mercuries & Associates Holding, Ltd. in January 2015.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.38% | -0.75% | -8.28% | -16.61% | -9.52% | -16.09% | +4.31% | -11.39% | -37.03% | -0.82% | +10.83% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%-4.4% Q1'26: -53.4% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%-50.4% Q1'26: -74.0% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%-4.9% Q1'26: -29.7% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+1.0% Q1'26: +0.1% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+3.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%-0.7% ★ Q1'26: -2.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×10.25× ★ Q1'26: 15.41× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 189.0K | 0.65% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 13.0K | 0.42% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 138.4K | 0.46% |
| 4 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 15.5K | 0.56% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 588.0K | 0.06% |
| 6 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 320.0K | 0.39% |
| 7 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.00% | 11.1K | 0.33% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 184.7K | 0.28% |
| 9 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 365.7K | 0.33% |
| 10 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 43.1K | 0.26% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shiang-Li Chen | GM, President & Chairman | 10M | male |
| Chin-Hsin Hsu | Chief Sustainability Officer & Chief Legal Officer | 8M | female |
| Chih-Hua Wang | Chief Information Security Officer, Asst GM, Principal Financial Officer & Head of Corporate Gov | 8M | male |
| Linxin Xu | Legal Affairs Director | 8M | — |
| Zhi Hua Wang | Vice President of Corporation Service Department and Treasurer | 7M | — |
| Te-Kai Chin | Assistant GM, Principal Accounting Officer & Vice President of Accounting | 3M | male |
| Kuang-Lung Chiu | President of Home Purchase Division | — | male |
| Guo Zheng Shen | President of Family Portrait Department | — | — |
| Xiang Fen Chen | President of Food Business Department | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2905.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
